Skip to main content

Table 1 Anthropometric, hormonal, metabolic and ultrasonographic characteristics of all patients with polycystic ovary syndrome (PCOS) and all controls.

From: The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study

  Group I
(patients with PCOS)
(n = 200)
Group II
(controls)
(n = 50)
p
(adjusted for age and BMI)
Age (years) 24.5 ± 5.3 32.6 ± 4.7 NA
BMI (kg/m2) 27.0 ± 6.4 25.1 ± 4.0 NA
Waist (cm) 83.5 ± 14.9 80.8 ± 10.1 NS
FSH (mIU/ml) 6.4 ± 1.9 7.9 ± 2.8 0.007
LH (mIU/ml) 7.6 ± 5.0 5.9 ± 2.8 NS
Prolactin (ng/ml) 14.3 ± 6.9 12.2 ± 4.3 NS
Testosterone (ng/dl) 75.1 ± 30.1 32.9 ± 14.4 < 0.001
Δ4-A (ng/ml) 2.9 ± 1.0 1.7 ± 0.5 < 0.001
DHEA-S (ng/ml) 3106.0 ± 1300.8 1944.6 ± 811.8 < 0.001
FAI 7.64 ± 6.1 1.98 ± 1.16 0.002
17α-OHP (ng/ml) 1.1 ± 0.5 0.7 ± 0.3 0.010
SHBG (nmol/l) 47.1 ± 28.1 69.2 ± 33.7 NS
Glucose (mg/dl) 98.5 ± 21.5 97.0 ± 9.8 NS
Insulin (μIU/ml) 12.4 ± 9.1 9.2 ± 6.8 NS
Glucose/insulin 11.52 ± 6.7 14.86 ± 9.03 NS
HOMA-IR 3.22 ± 3.90 2.24 ± 1.71 NS
QUICKI 0.34 ± 0.03 0.35 ± 0.03 NS
Area under the OGTT curve 15143.9 ± 3134.1 14565.6 ± 3352.5 NS
Mean ovarian volume (cm3) 9.8 ± 4.9 5.3 ± 1.8 < 0.001
Mean number of ovarian follicles 10.8 ± 4.7 6.2 ± 1.9 < 0.001
Lipocalin (ng/ml) 65.4 ± 34.3 60.3 ± 26.0 NS
  1. NA, not applicable; NS, not significant; BMI, body mass index; FSH, follicle stimulating hormone; LH, luteinizing hormone; Δ4-A, Δ4-androstenedione; DHEA-S, dehydroepiandrosterone sulfate; FAI, free androgen index; 17α-OHP, 17α-hydroxyprogesterone; SHBG, sex hormone-binding globulin; OGTT, oral glucose tolerance test; HOMA-IR, homeostasis model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check index